Development and Introduction of Fexinidazole into the Global Human African Trypanosomiasis Program

In this article, the authors show the strategy used to streamline the introduction of fexinidazole, the first all oral treatment of human African trypanosomiasis (HAT) caused by Trypanosoma brucei gambiense. The dose range was determined in phase 1 studies and a significant food effect was observed,...

Descripción completa

Detalles Bibliográficos
Autores principales: Valverde Mordt, Olaf, Tarral, Antoine, Strub-Wourgaft, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154641/
https://www.ncbi.nlm.nih.gov/pubmed/35292581
http://dx.doi.org/10.4269/ajtmh.21-1176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154641/
https://www.ncbi.nlm.nih.gov/pubmed/35292581
http://dx.doi.org/10.4269/ajtmh.21-1176

Ejemplares similares